NSW Regional Health Partners successful in MRFF RART Initiative Stream 3

NSW Regional Health Partners is delighted to be a part of the successful project team for Stream 3 of the Medical Research Future Fund (MRFF) Rapid Applied Research Translation (RART) Grant. This project, to be led by Dr Simon Deeming from Hunter Medical Research Institute, will evaluate the impact and effectiveness of the 2020 and 2022 rounds of the MRFF RART Initiative.

The RART Initiative supports the translation of research evidence into clinical practice to deliver better quality care for patients. Our evaluation of the projects funded in the 2020 and 2022 funding rounds will improve understanding of the factors that promote the adoption, impact and sustainability of evidence-based practice in health care.

Associate Professor Nicolette Hodyl, NSW Regional Health Partners Director, expressed enthusiasm for the project, “We are excited to be on this journey and look forward to collaborating with Dr Deeming and the project team. Our comprehensive evaluation of the funded projects will help identify the factors that support the effective implementation of evidence-based practice in health care. This will enable research findings to be embedded in health care and health services much more quickly than they are now.”

Almost $100 million has been awarded in the two grant rounds being evaluated, representing 18 projects across five states and territories.

The evaluation team also includes A/Prof. Penny Reeves, Dr. Shanthi Ramanathan, Toni Manton and Gillian Mason from HMRI, Prof. Mariko Carey from the Central Coast Research Institute, Prof. Kim Usher from the University of New England, Prof. Nicholas Goodwin, Prof. Luke Wolfenden, and Prof. John Attia from the University of Newcastle, and Dr Megan Williams from Wiradjuri country; a strong team with and considerable expertise and a reputation for leadership in research translation, impact assessment and evaluation.